MEDTRONIC ENTERS CSF SHUNT MARKET THROUGH PS MEDICAL ACQUISITION; STOCK-FOR- STOCK TRANSACTION ALSO COULD FILL OUT DRUG DELIVERY SYSTEM OFFERINGS
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is tapping into the cerebrospinal fluid (CSF) shunt market with the acquisition of PS Medical of Goleta, California in a stock-for-stock deal. Financial terms of the pact, announced Oct. 12, were not disclosed.